nodes	percent_of_prediction	percent_of_DWPC	metapath
Exemestane—CYP19A1—polycystic ovary syndrome	0.793	1	CbGaD
Exemestane—CYP19A1—follicular fluid—polycystic ovary syndrome	0.0533	0.424	CbGeAlD
Exemestane—CYP19A1—corpus luteum—polycystic ovary syndrome	0.0307	0.244	CbGeAlD
Exemestane—CYP19A1—ovarian follicle—polycystic ovary syndrome	0.024	0.191	CbGeAlD
Exemestane—CYP19A1—Ovarian Infertility Genes—GDF9—polycystic ovary syndrome	0.00526	0.108	CbGpPWpGaD
Exemestane—CYP3A4—urine—polycystic ovary syndrome	0.00487	0.0387	CbGeAlD
Exemestane—CYP19A1—endometrium—polycystic ovary syndrome	0.00238	0.0189	CbGeAlD
Exemestane—CYP19A1—uterus—polycystic ovary syndrome	0.00219	0.0174	CbGeAlD
Exemestane—CYP19A1—adipose tissue—polycystic ovary syndrome	0.00214	0.017	CbGeAlD
Exemestane—CYP19A1—Ovarian Infertility Genes—LHCGR—polycystic ovary syndrome	0.00202	0.0413	CbGpPWpGaD
Exemestane—CYP19A1—adrenal gland—polycystic ovary syndrome	0.00192	0.0153	CbGeAlD
Exemestane—CYP19A1—female gonad—polycystic ovary syndrome	0.00179	0.0142	CbGeAlD
Exemestane—CYP3A4—Benzo(a)pyrene metabolism—AKR1C2—polycystic ovary syndrome	0.00176	0.036	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of steroid hormones and vitamin D—SRD5A1—polycystic ovary syndrome	0.00169	0.0346	CbGpPWpGaD
Exemestane—CYP19A1—FSH signaling pathway—FSHR—polycystic ovary syndrome	0.00169	0.0346	CbGpPWpGaD
Exemestane—CYP19A1—endocrine gland—polycystic ovary syndrome	0.00167	0.0132	CbGeAlD
Exemestane—Dydrogesterone—PGR—polycystic ovary syndrome	0.00163	0.23	CrCbGaD
Exemestane—CYP19A1—Metabolism of steroid hormones and vitamin D—STAR—polycystic ovary syndrome	0.00162	0.0331	CbGpPWpGaD
Exemestane—CYP19A1—Ovarian Infertility Genes—FSHR—polycystic ovary syndrome	0.00148	0.0302	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of steroid hormones and vitamin D—HSD3B1—polycystic ovary syndrome	0.00137	0.0281	CbGpPWpGaD
Exemestane—CYP19A1—Endogenous sterols—CYP11A1—polycystic ovary syndrome	0.00129	0.0264	CbGpPWpGaD
Exemestane—Neuropathy—Metformin—polycystic ovary syndrome	0.00127	0.0504	CcSEcCtD
Exemestane—CYP19A1—Metabolism of steroid hormones and vitamin D—LHB—polycystic ovary syndrome	0.00125	0.0256	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of steroid hormones and vitamin D—HSD3B2—polycystic ovary syndrome	0.00122	0.025	CbGpPWpGaD
Exemestane—CYP19A1—Endogenous sterols—CYP17A1—polycystic ovary syndrome	0.0012	0.0245	CbGpPWpGaD
Exemestane—Pain in extremity—Metformin—polycystic ovary syndrome	0.000985	0.039	CcSEcCtD
Exemestane—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—polycystic ovary syndrome	0.000978	0.02	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP11A1—polycystic ovary syndrome	0.000967	0.0198	CbGpPWpGaD
Exemestane—CYP19A1—Ovarian Infertility Genes—PGR—polycystic ovary syndrome	0.000912	0.0187	CbGpPWpGaD
Exemestane—Testolactone—CYP19A1—polycystic ovary syndrome	0.000906	0.128	CrCbGaD
Exemestane—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP17A1—polycystic ovary syndrome	0.000899	0.0184	CbGpPWpGaD
Exemestane—Cramp muscle—Metformin—polycystic ovary syndrome	0.000887	0.0351	CcSEcCtD
Exemestane—Angina pectoris—Metformin—polycystic ovary syndrome	0.000829	0.0328	CcSEcCtD
Exemestane—Sweating increased—Metformin—polycystic ovary syndrome	0.000829	0.0328	CcSEcCtD
Exemestane—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000808	0.00642	CbGeAlD
Exemestane—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000791	0.0313	CcSEcCtD
Exemestane—Estropipate—SHBG—polycystic ovary syndrome	0.000769	0.109	CrCbGaD
Exemestane—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—polycystic ovary syndrome	0.000753	0.0154	CbGpPWpGaD
Exemestane—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000744	0.0294	CcSEcCtD
Exemestane—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000718	0.0284	CcSEcCtD
Exemestane—Rhinitis—Metformin—polycystic ovary syndrome	0.000683	0.027	CcSEcCtD
Exemestane—Hepatitis—Metformin—polycystic ovary syndrome	0.000681	0.027	CcSEcCtD
Exemestane—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000678	0.0268	CcSEcCtD
Exemestane—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000671	0.0266	CcSEcCtD
Exemestane—Loteprednol—NR3C1—polycystic ovary syndrome	0.000669	0.0947	CrCbGaD
Exemestane—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000632	0.025	CcSEcCtD
Exemestane—CYP19A1—Ovarian Infertility Genes—NCOR1—polycystic ovary syndrome	0.00062	0.0127	CbGpPWpGaD
Exemestane—Immune system disorder—Metformin—polycystic ovary syndrome	0.000615	0.0244	CcSEcCtD
Exemestane—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000599	0.0123	CbGpPWpGaD
Exemestane—CYP19A1—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000591	0.0121	CbGpPWpGaD
Exemestane—CYP19A1—Endogenous sterols—POMC—polycystic ovary syndrome	0.00057	0.0117	CbGpPWpGaD
Exemestane—Muscle spasms—Metformin—polycystic ovary syndrome	0.00057	0.0226	CcSEcCtD
Exemestane—CYP19A1—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000561	0.0115	CbGpPWpGaD
Exemestane—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000557	0.0114	CbGpPWpGaD
Exemestane—CYP19A1—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00055	0.0112	CbGpPWpGaD
Exemestane—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.000541	0.0111	CbGpPWpGaD
Exemestane—Malaise—Metformin—polycystic ovary syndrome	0.000535	0.0212	CcSEcCtD
Exemestane—Hypertension—Metformin—polycystic ovary syndrome	0.000512	0.0203	CcSEcCtD
Exemestane—Chest pain—Metformin—polycystic ovary syndrome	0.000505	0.02	CcSEcCtD
Exemestane—Myalgia—Metformin—polycystic ovary syndrome	0.000505	0.02	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000501	0.0198	CcSEcCtD
Exemestane—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—polycystic ovary syndrome	0.000495	0.0101	CbGpPWpGaD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000486	0.00994	CbGpPWpGaD
Exemestane—Oedema—Metformin—polycystic ovary syndrome	0.000484	0.0192	CcSEcCtD
Exemestane—Infection—Metformin—polycystic ovary syndrome	0.000481	0.019	CcSEcCtD
Exemestane—Estrone—SHBG—polycystic ovary syndrome	0.000479	0.0677	CrCbGaD
Exemestane—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000475	0.0188	CcSEcCtD
Exemestane—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000474	0.0188	CcSEcCtD
Exemestane—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.000473	0.00968	CbGpPWpGaD
Exemestane—Skin disorder—Metformin—polycystic ovary syndrome	0.00047	0.0186	CcSEcCtD
Exemestane—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000468	0.0185	CcSEcCtD
Exemestane—Anorexia—Metformin—polycystic ovary syndrome	0.000461	0.0183	CcSEcCtD
Exemestane—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000457	0.00935	CbGpPWpGaD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000452	0.00924	CbGpPWpGaD
Exemestane—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000441	0.0174	CcSEcCtD
Exemestane—CYP19A1—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000439	0.00899	CbGpPWpGaD
Exemestane—Paraesthesia—Metformin—polycystic ovary syndrome	0.000435	0.0172	CcSEcCtD
Exemestane—Dyspnoea—Metformin—polycystic ovary syndrome	0.000431	0.0171	CcSEcCtD
Exemestane—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—polycystic ovary syndrome	0.000427	0.00874	CbGpPWpGaD
Exemestane—Dyspepsia—Metformin—polycystic ovary syndrome	0.000426	0.0169	CcSEcCtD
Exemestane—Decreased appetite—Metformin—polycystic ovary syndrome	0.000421	0.0166	CcSEcCtD
Exemestane—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000418	0.0165	CcSEcCtD
Exemestane—Fatigue—Metformin—polycystic ovary syndrome	0.000417	0.0165	CcSEcCtD
Exemestane—Methylprednisolone—NR3C1—polycystic ovary syndrome	0.000417	0.059	CrCbGaD
Exemestane—Constipation—Metformin—polycystic ovary syndrome	0.000414	0.0164	CcSEcCtD
Exemestane—Testosterone—CYP11A1—polycystic ovary syndrome	0.000413	0.0584	CrCbGaD
Exemestane—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000399	0.0158	CcSEcCtD
Exemestane—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000396	0.0157	CcSEcCtD
Exemestane—Urticaria—Metformin—polycystic ovary syndrome	0.000384	0.0152	CcSEcCtD
Exemestane—Abdominal pain—Metformin—polycystic ovary syndrome	0.000383	0.0151	CcSEcCtD
Exemestane—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000355	0.00727	CbGpPWpGaD
Exemestane—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000351	0.00717	CbGpPWpGaD
Exemestane—Asthenia—Metformin—polycystic ovary syndrome	0.000347	0.0137	CcSEcCtD
Exemestane—Pruritus—Metformin—polycystic ovary syndrome	0.000342	0.0136	CcSEcCtD
Exemestane—Diarrhoea—Metformin—polycystic ovary syndrome	0.000331	0.0131	CcSEcCtD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000326	0.00668	CbGpPWpGaD
Exemestane—Dizziness—Metformin—polycystic ovary syndrome	0.00032	0.0127	CcSEcCtD
Exemestane—Prednisone—NR3C1—polycystic ovary syndrome	0.000319	0.0451	CrCbGaD
Exemestane—CYP19A1—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000312	0.00639	CbGpPWpGaD
Exemestane—Vomiting—Metformin—polycystic ovary syndrome	0.000308	0.0122	CcSEcCtD
Exemestane—Rash—Metformin—polycystic ovary syndrome	0.000305	0.0121	CcSEcCtD
Exemestane—Dermatitis—Metformin—polycystic ovary syndrome	0.000305	0.0121	CcSEcCtD
Exemestane—Headache—Metformin—polycystic ovary syndrome	0.000303	0.012	CcSEcCtD
Exemestane—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000298	0.00611	CbGpPWpGaD
Exemestane—Prednisolone—NR3C1—polycystic ovary syndrome	0.000294	0.0416	CrCbGaD
Exemestane—CYP19A1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000291	0.00596	CbGpPWpGaD
Exemestane—Testosterone—SHBG—polycystic ovary syndrome	0.000291	0.0412	CrCbGaD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000288	0.00589	CbGpPWpGaD
Exemestane—Nausea—Metformin—polycystic ovary syndrome	0.000287	0.0114	CcSEcCtD
Exemestane—CYP19A1—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000287	0.00588	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000276	0.00566	CbGpPWpGaD
Exemestane—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000272	0.00556	CbGpPWpGaD
Exemestane—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000265	0.00542	CbGpPWpGaD
Exemestane—Estrone—CYP1A1—polycystic ovary syndrome	0.000258	0.0366	CrCbGaD
Exemestane—CYP19A1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000258	0.00528	CbGpPWpGaD
Exemestane—Testosterone—AR—polycystic ovary syndrome	0.000255	0.0361	CrCbGaD
Exemestane—CYP19A1—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000254	0.00521	CbGpPWpGaD
Exemestane—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00025	0.00511	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00024	0.00492	CbGpPWpGaD
Exemestane—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00024	0.00491	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00024	0.00491	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000237	0.00484	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—ATF1—polycystic ovary syndrome	0.000234	0.00478	CbGpPWpGaD
Exemestane—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.000231	0.00472	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000218	0.00447	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000218	0.00447	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—TAB1—polycystic ovary syndrome	0.000216	0.00441	CbGpPWpGaD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000215	0.00439	CbGpPWpGaD
Exemestane—Testosterone—CYP19A1—polycystic ovary syndrome	0.000214	0.0302	CrCbGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—AR—polycystic ovary syndrome	0.000205	0.00419	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000183	0.00375	CbGpPWpGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000175	0.00358	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—BAX—polycystic ovary syndrome	0.000175	0.00357	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000174	0.00355	CbGpPWpGaD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000173	0.00353	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000166	0.00339	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000164	0.00335	CbGpPWpGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000163	0.00333	CbGpPWpGaD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00016	0.00328	CbGpPWpGaD
Exemestane—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000159	0.00326	CbGpPWpGaD
Exemestane—Testosterone—CYP1A1—polycystic ovary syndrome	0.000157	0.0222	CrCbGaD
Exemestane—CYP19A1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000153	0.00313	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000151	0.00309	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000142	0.0029	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000141	0.00288	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000135	0.00275	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000132	0.0027	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	0.000131	0.00269	CbGpPWpGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000129	0.00263	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000128	0.00263	CbGpPWpGaD
Exemestane—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000128	0.00262	CbGpPWpGaD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000127	0.0026	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000125	0.00257	CbGpPWpGaD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000123	0.00253	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SUOX—polycystic ovary syndrome	0.000123	0.00252	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000123	0.00252	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000122	0.00249	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000114	0.00234	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—POMC—polycystic ovary syndrome	0.000114	0.00233	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000112	0.00229	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	0.000106	0.00217	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000104	0.00214	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000104	0.00213	CbGpPWpGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000104	0.00212	CbGpPWpGaD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000102	0.00209	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	9.91e-05	0.00203	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—TEAD2—polycystic ovary syndrome	9.73e-05	0.00199	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AKR1C2—polycystic ovary syndrome	9.73e-05	0.00199	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	9.36e-05	0.00191	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	9.21e-05	0.00188	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	9.11e-05	0.00186	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	8.5e-05	0.00174	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	8.41e-05	0.00172	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	8.38e-05	0.00172	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PNPLA2—polycystic ovary syndrome	8.15e-05	0.00167	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	7.95e-05	0.00163	CbGpPWpGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	7.73e-05	0.00158	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SRD5A1—polycystic ovary syndrome	7.73e-05	0.00158	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	7.53e-05	0.00154	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	7.43e-05	0.00152	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—STAR—polycystic ovary syndrome	7.37e-05	0.00151	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	7.01e-05	0.00143	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	7e-05	0.00143	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	6.9e-05	0.00141	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HMMR—polycystic ovary syndrome	6.57e-05	0.00134	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HSD3B1—polycystic ovary syndrome	6.27e-05	0.00128	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	6.27e-05	0.00128	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.2e-05	0.00127	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	5.88e-05	0.0012	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—LHB—polycystic ovary syndrome	5.72e-05	0.00117	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HSD3B2—polycystic ovary syndrome	5.59e-05	0.00114	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	5.54e-05	0.00113	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	5.46e-05	0.00112	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AKR1C1—polycystic ovary syndrome	5.41e-05	0.00111	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SULT2A1—polycystic ovary syndrome	4.98e-05	0.00102	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—RRM2—polycystic ovary syndrome	4.82e-05	0.000987	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—YAP1—polycystic ovary syndrome	4.65e-05	0.000951	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NAMPT—polycystic ovary syndrome	4.47e-05	0.000914	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	4.46e-05	0.000914	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.44e-05	0.000909	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP11A1—polycystic ovary syndrome	4.41e-05	0.000903	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	4.4e-05	0.000901	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.38e-05	0.000896	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AKR1C3—polycystic ovary syndrome	4.17e-05	0.000853	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP17A1—polycystic ovary syndrome	4.1e-05	0.000839	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	3.93e-05	0.000804	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	3.59e-05	0.000735	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	3.59e-05	0.000735	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—TH—polycystic ovary syndrome	3.55e-05	0.000726	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SLC2A4—polycystic ovary syndrome	3.45e-05	0.000706	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	3.34e-05	0.000683	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	3.33e-05	0.000681	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GNAS—polycystic ovary syndrome	2.9e-05	0.000593	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	2.84e-05	0.000581	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	2.84e-05	0.000581	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NCOR1—polycystic ovary syndrome	2.76e-05	0.000565	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP1A1—polycystic ovary syndrome	2.62e-05	0.000535	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—MTHFR—polycystic ovary syndrome	2.44e-05	0.000499	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	2.38e-05	0.000487	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	2.26e-05	0.000462	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	2.15e-05	0.00044	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PPARG—polycystic ovary syndrome	1.98e-05	0.000405	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—POMC—polycystic ovary syndrome	1.95e-05	0.000399	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—INS—polycystic ovary syndrome	1.94e-05	0.000397	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.92e-05	0.000392	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.83e-05	0.000374	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.67e-05	0.000341	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.63e-05	0.000334	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.58e-05	0.000323	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.45e-05	0.000297	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.41e-05	0.000288	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.36e-05	0.000278	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.3e-05	0.000267	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.29e-05	0.000263	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.22e-05	0.000249	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.2e-05	0.000245	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.04e-05	0.000212	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.01e-05	0.000206	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	9.47e-06	0.000194	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	8.46e-06	0.000173	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	8.05e-06	0.000165	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	7.64e-06	0.000156	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	7.12e-06	0.000146	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	5.77e-06	0.000118	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	5.69e-06	0.000116	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—INS—polycystic ovary syndrome	5.66e-06	0.000116	CbGpPWpGaD
